Loading
Cegedim Stock: price and insider trades · France
No insider purchase over the last 90 days. The latest, by FCB SAS, was filed 28 Apr 2026.
Cegedim: what insiders have been doing
This page follows insider dealings at Cegedim as filed with AMF, a company from the Technology sector based in Boulogne-Billancourt, France. The group dates from 1969. The last twelve months, up to 23 October 2026, brought 62 filings signed by 2 insiders.
No insider sold shares on the market over the period. Instead, the filings list 62 purchases totalling €5.0M, made by 2 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 2 board members. One trade stands out by size: a purchase of €1.3M from FCB SAS, disclosed on 2 March 2026, or 0.88% of market capitalisation.
In the case of 21 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 28 April 2026, 178 days ago. The median gap between a trade and its publication by AMF is 1 day. The legal deadline for notifying a trade is three business days (MAR article 19).
Compared with its exchange (313 companies, median 7 filings), a count of 62 filings is above the norm. Since 2021, the database holds 319 purchases and no sales by insiders of the company.
Other companies in the same sector with recent insider buying flagged by our signals: Hanza AB and Lime Technologies AB (publ). Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Insider Decl.
324
Thresholds
n/a
Buy Volume
€17M
319 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleFCB SAS114 buys
Pierre Marucchi19 buys
Fcb1 buy
Frédéric Duchesne1 buy
Since the insiders bought
- -14.2%Entry €12.00 · Close 22 Oct 2026 €10.30
- -25.1%Entry €13.75 · Close 22 Oct 2026 €10.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Cegedim Buy (bullish), based on 3 analysts. Average price target: €15.13.
Fundamental score
Ranked 2,310 of 26,248 companies
75.1
score / 100
Value90
Quality60
FCF yld55%
Earn yld6.7%
EV/EBITDA1.8x
ROE4.3%
Gross mgn86%
Net mgn1.4%
Debt/EBITDA0.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€10.28
Analyst consensus
3 analystsBuy
€11.00Target €15.13(+47%)€20.00
Income statement
Revenue€649.2M
Gross profit€559.2M86% margin
EBITDA€128.2M20% margin
Net income€9.4M2.1% margin
Valuation
PER (trailing)10.8x
PER (forward)6.9x
P/Book0.5x
Beta0.57
Balance sheet & cash
Market cap€141.1M
Total debt€93.8M
Free Cash Flow€78.3M
Debt / Equity108%
Profitability & ownership
ROE4.3%
ROA2.4%
% insiders60.9%
% institutions11.7%
Last declaration on 28 April 2026
Declarations324 total
751 shares@ €11.99140.0057% mcap0.1% of flowActionEuronext Growth ParisISIN FR00000535062026DD1110609
Canonical exit: 26 Jul 2026 (T+90)
74,537 shares@ €11.99960.57% mcap6.7% of flowActionEuronext Growth ParisISIN FR00000535062026DD1110304
Canonical exit: 23 Jul 2026 (T+90)
500 shares@ €12.000.0040% mcap0.0% of flowActionEuronext Growth ParisISIN FR00000535062026DD1107910
Canonical exit: 13 Jul 2026 (T+90)
1,239 shares@ €10.77950.1% of flowActionEuronext Growth ParisISIN FR00000535062026DD1104491
Canonical exit: 28 Jun 2026 (T+90)
7,027 shares@ €10.9890.052% mcap0.6% of flowActionEuronext Growth ParisISIN FR00000535062026DD1104156
Canonical exit: 25 Jun 2026 (T+90)
7,524 shares@ €10.42830.053% mcap0.6% of flowActionEuronext Growth ParisISIN FR00000535062026DD1099088
Canonical exit: 3 Jun 2026 (T+90)
8,051 shares@ €10.53110.057% mcap0.6% of flowActionEuronext Growth ParisISIN FR00000535062026DD1098733
Canonical exit: 2 Jun 2026 (T+90)
1,517 shares@ €10.2580.011% mcap0.1% of flowActionEuronext Growth ParisISIN FR00000535062026DD1098470
Canonical exit: 1 Jun 2026 (T+90)
13,419 shares@ €10.3370.094% mcap1.0% of flowActionEuronext Growth ParisISIN FR00000535062026DD1098110
Canonical exit: 31 May 2026 (T+90)
121,659 shares@ €10.74940.88% mcap9.7% of flowActionEuronext Growth ParisISIN FR00000535062026DD1097711
Canonical exit: 28 May 2026 (T+90)
709 shares@ €11.65130.0056% mcap0.1% of flowActionEuronext Growth ParisISIN FR00000535062026DD1097420
Canonical exit: 27 May 2026 (T+90)
5,203 shares@ €11.74790.041% mcap0.5% of flowActionEuronext Growth ParisISIN FR00000535062026DD1097131
Canonical exit: 26 May 2026 (T+90)
2,251 shares@ €11.90360.018% mcap0.2% of flowActionEuronext Growth ParisISIN FR00000535062026DD1096856
Canonical exit: 25 May 2026 (T+90)
2,082 shares@ €11.93320.017% mcap0.2% of flowActionEuronext Growth ParisISIN FR00000535062026DD1096583
Canonical exit: 24 May 2026 (T+90)
5,922 shares@ €11.76590.5% of flowActionEuronext Growth ParisISIN FR00000535062026DD1096298
Canonical exit: 21 May 2026 (T+90)
10,645 shares@ €12.15161.0% of flowActionEuronext Growth ParisISIN FR00000535062026DD1096057
Canonical exit: 20 May 2026 (T+90)
4,435 shares@ €12.32380.4% of flowActionEuronext Growth ParisISIN FR00000535062026DD1095773
Canonical exit: 19 May 2026 (T+90)
3,072 shares@ €12.99290.3% of flowActionEuronext Growth ParisISIN FR00000535062026DD1095229
Canonical exit: 17 May 2026 (T+90)
14,201 shares@ €12.89241.4% of flowActionEuronext Growth ParisISIN FR00000535062026DD1094957
Canonical exit: 14 May 2026 (T+90)
9,737 shares@ €12.88990.9% of flowActionEuronext Growth ParisISIN FR00000535062026DD1094714
Canonical exit: 13 May 2026 (T+90)
5,221 shares@ €13.0620.5% of flowActionEuronext Growth ParisISIN FR00000535062026DD1094400
Canonical exit: 12 May 2026 (T+90)
3,346 shares@ €13.00050.3% of flowActionEuronext Growth ParisISIN FR00000535062026DD1094182
Canonical exit: 11 May 2026 (T+90)
3,707 shares@ €12.91850.4% of flowActionEuronext Growth ParisISIN FR00000535062026DD1093903
Canonical exit: 10 May 2026 (T+90)
10,240 shares@ €12.70771.0% of flowActionEuronext Growth ParisISIN FR00000535062026DD1093628
Canonical exit: 7 May 2026 (T+90)
19,300 shares@ €13.0471.9% of flowActionEuronext Growth ParisISIN FR00000535062026DD1093352
Canonical exit: 6 May 2026 (T+90)
25 of 324 declarations
About Cegedim
Cegedim is a French technology and services group founded in 1969, historically positioned at the intersection of healthcare, software, and data-flow management. Listed on Euronext Paris under ISIN FR0000053506, the company has built its business over several decades around a strong specialization in digital solutions for healthcare professionals, pharmaceutical companies, health insurers, and, more broadly, enterprises that require industry-specific software and outsourced services. According to its 2024 Universal Registration Document, Cegedim is a French public limited company headquartered in Boulogne-Billancourt, and the group operates in more than 10 countries with nearly 6,500 employees as of 2025 and continuing activities revenue above €649 million in 2025.
The group’s business model is built on several complementary operating lines. Cegedim Santé serves healthcare professionals with practice management software, online scheduling tools, drug databases, and prescription support solutions. Activities aimed at healthcare companies and pharmaceutical groups include databases, marketing intelligence, studies, and customer relationship management tools. Cegedim Business Services focuses on healthcare data flows and administrative processes, including data processing, digitalization, and certain business process outsourcing offerings. The group also develops software and services for human resources and complementary health insurance providers.
Read moreShow less
In 2024, Cegedim generated €654.5 million in revenue, up 6.3% year on year, while recurring operating income rose to €39.5 million, representing a 6.0% margin versus 5.1% in 2023. This improvement reflects better operating profitability and a favorable scope effect, within a context of continued portfolio optimization and disciplined management of the business mix. Revenue remains largely driven by France, but the company also has a meaningful international footprint, particularly across Europe, with operations and subsidiaries in Belgium, Spain, the United Kingdom, Romania, and other markets where it maintains local activities or offshore delivery centers.
Cegedim’s market position is that of a specialized, niche technology provider with recognized expertise in healthcare software and data-driven services. Its long operating history, deep regulatory know-how, and a meaningful share of recurring revenues are strategic strengths. For investors, the company offers exposure to the ongoing digital transformation of healthcare systems and enterprise services, with a business profile combining software, data, and outsourced workflows.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
